As the Founder & CEO of a forward-thinking pharmaceutical company, I have led the development and successful launch of over 60 high-impact formulations across key therapeutic areas including cardiology, oncology, and anti-infectives. Under my leadership, we expanded our manufacturing capabilities by establishing state-of-the-art facilities fully compliant with WHO-GMP and other international quality standards. Over the past eight years, the company has witnessed a 300% revenue growth, driven by operational excellence, product innovation, and strategic market expansion. I’ve had the privilege of building and mentoring a team of over 200 professionals spanning R&D, production, regulatory affairs, and marketing, fostering a culture rooted in innovation, accountability, and collaboration. Our products have achieved regulatory approvals in highly competitive global markets such as the US, European Union, and Southeast Asia a testament to our uncompromising commitment to quality and compliance. Our mission, “Trusted Science, Better Lives,” defines every decision we make from formulation design to frontline healthcare delivery. I firmly believe in creating sustainable growth through ethical practices, scientific integrity, and a relentless focus on improving patient outcomes. I welcome connections with professionals and innovators in healthcare, life sciences, and global impact sectors and am always open to exploring meaningful collaborations that move the industry forward.